ImmuPharma PLC raises £3.55mln at a significant premium to Friday's share price
The cash injection will be used to fund research and development
Source: proactiveinvestors.co.uk
Stay updated with breaking news from Lanstead Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The cash injection will be used to fund research and development
The cash injection will be used to fund research and development
A look at the major movers on the London market on Monday
It has inked a subscription agreement with Lannstead Capital
Nuformix PLC (LSE:NFX) (Nuformix PLC (LSE:NFX)) chairman Dr Alastair Riddell talks to Proactive about raising £1.65mln via a subscription...